EATG » Scientific research

Scientific research

Active substance raises hopes of curing hepatitis E

There is no specific therapy for hepatitis E to date: around 70,000 people worldwide die from it every year. An international team of researchers has now found a possible active…

AIDS 2018: Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved

24 July 2018 - Researchers have reported the results of the first randomised clinical trial to test a novel strategy. The approach involves waking up and then killing the ‘sleeping’…

Research shows a promising new class of antibodies protects against HIV-1 infection

A group of scientists at Texas Biomed have zeroed in on a new defense against HIV-1, the virus that causes AIDS. Led by Ruth Ruprecht, M.D., Ph.D., the team used…

2018 TAG Pipeline Report

Treatment Action Group (TAG) released the 2018 Pipeline Report - TAG’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, HCV, and TB, along with immune-based…

Swift gene-editing method may revolutionize treatments for cancer and infectious diseases

Scientists report that they have discovered a way to tweak genes in the body’s immune cells by using electrical fields. For the first time, scientists have found a way to…

Imaging technique illuminates immune status of monkeys with HIV-like virus

Approach could improve understanding of immune system recovery in people treated for HIV infection Findings from an animal study suggest that a non-invasive imaging technique could, with further development, become…

Gammaherpesviruses linked to tumors in macaques with simian immunodeficiency virus

Future macaque research could help clarify viruses' roles in cancer development in people with HIV Viruses known as gammaherpesviruses may raise the risk of cancer in macaques infected with Simian…

Breakthrough study shows how HIV is shielded from immune attack

A UNSW study has shown for the first time how HIV hijacks a host molecule to strengthen its protective shell and shield itself from attack. The findings have implications for…

NIH and Matinas BioPharma announce research collaboration to identify novel HIV therapy utilizing LNC platform delivery technology

Development program to focus on combination of antisense oligonucleotides with Matinas’ Proprietary LNC Delivery Technology BEDMINSTER, N.J. and WASHINGTON, July 09, 2018 -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical…

Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection

-- Extended dosing with ABX464 observed to be safe and well-tolerated. -- Decrease in Total HIV DNA in blood observed with longer treatment. -- For the first time, HIV DNA…